Academic Integrity: tutoring, explanations, and feedback — we don’t complete graded work or submit on a student’s behalf.

XYZ Pharmaceutical, Inc. just got FDA approval for their new drug, Viagrina. The

ID: 2740954 • Letter: X

Question

XYZ Pharmaceutical, Inc. just got FDA approval for their new drug, Viagrina. The company has never paid a dividend, but they expect to pay one for the first time by the end of the year. The expected dividend is $3.00 per share and the company expects that dividend to increase at a rate of 20% for five years. After that, XYZ expects to see its dividend growth limited by the growth rate the US economy, which on average is 4.5% per year. If the required rate of return for other startup pharmaceutical companies like XYZ is 11%, what should be the fair price of XYZ’s stock today? please show me how to do this on my financial calculator

Explanation / Answer

First work out the cash-flows -

Year 1 - 3

Year 2 - 3 * 1.21 = 3.6

Year 3 - 3 * 1.22 = 4.32

Year 4 - 3 * 1.23 = 5.18

Year 5 - 3 * 1.24 = 6.22

Year 6 - 3 * 1.25 = 7.46

The high growth period ends at Year 6, so we also need to find the terminal value = D6 (1+g) / (Ke-g)

= 7.46 * 1.045 / (0.11-0.045)

= 120.51

Thus, the total cash-flows for year 6 = 7.46 + 120.51 = 127.97

Now, all the cash-flows can be entered into a financial calculator such as Texas BA II Plus -